{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:34:04Z","timestamp":1785368044339,"version":"3.55.0"},"reference-count":31,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1210\/jc.2017-00354","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T18:09:08Z","timestamp":1496858948000},"page":"2985-2993","source":"Crossref","is-referenced-by-count":17,"title":["Proton Pump Inhibitors, Nephropathy, and Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study"],"prefix":"10.1210","volume":"102","author":[{"given":"Timothy M E","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Drinkwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,6,7]]},"reference":[{"issue":"12","key":"key\n\t\t\t\t20170807140054_B1","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1161\/CIRCRESAHA.116.308807","article-title":"Proton pump inhibitors accelerate endothelial senescence","volume":"118","year":"2016","journal-title":"Circ Res"},{"issue":"4","key":"key\n\t\t\t\t20170807140054_B2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis","volume":"73","year":"2016","journal-title":"JAMA Neurol"},{"issue":"5","key":"key\n\t\t\t\t20170807140054_B3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40620-016-0309-2","article-title":"PPIs and kidney disease: from AIN to CKD","volume":"29","year":"2016","journal-title":"J Nephrol"},{"issue":"6","key":"key\n\t\t\t\t20170807140054_B4","doi-asserted-by":"crossref","first-page":"e0124653","DOI":"10.1371\/journal.pone.0124653","article-title":"Proton pump inhibitor usage and the risk of myocardial infarction in the general population","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170807140054_B5","doi-asserted-by":"crossref","first-page":"d2690","DOI":"10.1136\/bmj.d2690","article-title":"Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study","volume":"342","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"key\n\t\t\t\t20170807140054_B6","doi-asserted-by":"crossref","first-page":"e000262","DOI":"10.1161\/JAHA.113.000262","article-title":"The endothelium abridges insulin resistance to premature aging","volume":"2","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20170807140054_B7","first-page":"13","article-title":"Proteinuria and its relation to cardiovascular disease","volume":"7","year":"2013","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"4","key":"key\n\t\t\t\t20170807140054_B8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00285287","article-title":"Albuminuria reflects widespread vascular damage: the Steno hypothesis","volume":"32","year":"1989","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t20170807140054_B9","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1159\/000328015","article-title":"Microalbuminuria: marker or maker of cardiovascular disease","volume":"119","year":"2011","journal-title":"Nephron Exp Nephrol"},{"issue":"2","key":"key\n\t\t\t\t20170807140054_B10","first-page":"412","article-title":"Cohort profile: the Fremantle Diabetes Study","volume":"42","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"10","key":"key\n\t\t\t\t20170807140054_B11","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/dc12-0225","article-title":"Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: the Fremantle Diabetes Study","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"issue":"9","key":"key\n\t\t\t\t20170807140054_B12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"key\n\t\t\t\t20170807140054_B13","first-page":"685","article-title":"Angiotensin-converting enzyme inhibitor\u2013associated elevations in serum creatinine: is this a cause for concern?","volume":"160","year":"2000","journal-title":"Arch Intern Med"},{"issue":"7","key":"key\n\t\t\t\t20170807140054_B14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1464-5491.2011.03230.x","article-title":"Renin-angiotensin-aldosterone system blockade and urinary albumin excretion in community-based patients with type 2 diabetes: the Fremantle Diabetes Study","volume":"28","year":"2011","journal-title":"Diabet Med"},{"issue":"4","key":"key\n\t\t\t\t20170807140054_B15","first-page":"286","article-title":"An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study","volume":"40","year":"2009","journal-title":"Intern Med J"},{"issue":"10","key":"key\n\t\t\t\t20170807140054_B16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4239\/wjd.v6.i10.1122","article-title":"Effect of proton pump inhibitors on glycemic control in patients with diabetes","volume":"6","year":"2015","journal-title":"World J Diabetes"},{"issue":"1","key":"key\n\t\t\t\t20170807140054_B17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/apt.13649","article-title":"Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period","volume":"44","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"key\n\t\t\t\t20170807140054_B18","first-page":"23","article-title":"Proton pump inhibitors and the prescribing cascade","volume":"42","year":"2015","journal-title":"J Gerontol Nurs"},{"issue":"24","key":"key\n\t\t\t\t20170807140054_B19","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/CIR.0b013e318202f701","article-title":"ACCF\/ACG\/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents","volume":"122","author":"ACCF\/ACG\/AHA","year":"2010","journal-title":"Circulation"},{"issue":"7","key":"key\n\t\t\t\t20170807140054_B20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/gutjnl-2013-306393","article-title":"Symptomatic reflux disease: the present, the past and the future","volume":"63","year":"2014","journal-title":"Gut"},{"issue":"4","key":"key\n\t\t\t\t20170807140054_B21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1358863X14568444","article-title":"Proton pump inhibitors and vascular function: a prospective cross-over pilot study","volume":"20","year":"2015","journal-title":"Vasc Med"},{"issue":"2","key":"key\n\t\t\t\t20170807140054_B22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"15","key":"key\n\t\t\t\t20170807140054_B23","doi-asserted-by":"crossref","first-page":"e3363","DOI":"10.1097\/MD.0000000000003363","article-title":"Association between the use of proton pump inhibitors and the risk of ESRD in renal diseases: a population-based, case-control study","volume":"95","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"key\n\t\t\t\t20170807140054_B24","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1681\/ASN.2015121377","article-title":"Proton pump inhibitors and risk of incident CKD and progression to ESRD","volume":"27","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"key\n\t\t\t\t20170807140054_B25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5414\/CN10838","article-title":"Acute interstitial nephritis\u2014a reappraisal and update","volume":"82","year":"2014","journal-title":"Clin Nephrol"},{"issue":"1","key":"key\n\t\t\t\t20170807140054_B26","first-page":"73","article-title":"Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in Wistar rats","volume":"389","year":"2015","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1\u20133","key":"key\n\t\t\t\t20170807140054_B27","first-page":"435","article-title":"Proton pump inhibitors as also inhibitors of atrial fibrillation","volume":"718","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"key\n\t\t\t\t20170807140054_B28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.113.003602","article-title":"Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine","volume":"128","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"key\n\t\t\t\t20170807140054_B29","first-page":"660","article-title":"Magnesium deficiency and proton-pump inhibitor use: a clinical review","volume":"56","year":"2015","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"key\n\t\t\t\t20170807140054_B30","doi-asserted-by":"crossref","first-page":"e74355","DOI":"10.1371\/journal.pone.0074355","article-title":"The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170807140054_B31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejim.2016.10.007","article-title":"The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal","volume":"37","year":"2017","journal-title":"Eur J Intern Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/8\/2985\/19452733\/jc.2017-00354.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:33:38Z","timestamp":1659080018000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jcem\/article\/102\/8\/2985\/3861922\/Proton-Pump-Inhibitors-Nephropathy-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,7]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,6,7]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-00354","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,7]]}}}